Neal Walker Aclaris Therapeutics, Inc. (ACRS) insider trading activity

ACRS Quotes by TradingView

Neal Walker is INTERIM CEO of Aclaris Therapeutics, Inc.. Currently has a direct ownership of 1.45 Million shares of ACRS, which is worth approximately $3.59 Million. The most recent transaction as insider was on Feb 01, 2021, when has been sold 3,316 shares (Common Stock) at a price of $21.35 per share, resulting in proceeds of $70,797. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.45M
6.22% 3M change
14.26% 12M change
Total Value Held $3.59 Million

Neal Walker Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 01 2021
SELL
Payment of exercise price or tax liability
$70,797 $21.35 p/Share
3,316 Reduced 0.29%
1,155,798 Common Stock
Feb 01 2021
BUY
Exercise of conversion of derivative security
-
10,800 Added 0.92%
1,159,114 Common Stock
Dec 15 2020
SELL
Payment of exercise price or tax liability
$3,998 $4.59 p/Share
871 Reduced 0.08%
1,148,314 Common Stock
Dec 15 2020
BUY
Exercise of conversion of derivative security
-
3,034 Added 0.26%
1,149,185 Common Stock

Also insider at

ALDX
Aldeyra Therapeutics, Inc. Healthcare
NW

Neal Walker

INTERIM CEO
Wayne, PA

Track Institutional and Insider Activities on ACRS

Follow Aclaris Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ACRS shares.

Notify only if

Insider Trading

Get notified when an Aclaris Therapeutics, Inc. insider buys or sells ACRS shares.

Notify only if

News

Receive news related to Aclaris Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ACRS